<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d546" origId="Acebutolol"><sentence id="DrugDDI.d546.s0" origId="s0" text="Catecholamine-depleting drugs, such as reserpine, may have an additive effect when given with beta-blocking agents."><entity charOffset="24-29" id="DrugDDI.d546.s0.e0" origId="s0.p0" text="drugs" type="drug"/><entity charOffset="39-48" id="DrugDDI.d546.s0.e1" origId="s0.p1" text="reserpine" type="drug"/><entity charOffset="94-113" id="DrugDDI.d546.s0.e2" origId="s0.p7" text="beta-blocking agent" type="drug"/><pair e1="DrugDDI.d546.s0.e0" e2="DrugDDI.d546.s0.e1" id="DrugDDI.d546.s0.p0" interaction="false"/><pair e1="DrugDDI.d546.s0.e0" e2="DrugDDI.d546.s0.e2" id="DrugDDI.d546.s0.p1" interaction="true"/><pair e1="DrugDDI.d546.s0.e1" e2="DrugDDI.d546.s0.e2" id="DrugDDI.d546.s0.p2" interaction="false"/></sentence><sentence id="DrugDDI.d546.s1" origId="s1" text="Patients treated with acebutolol plus catecholamine depletors should, therefore, be observed closely for evidence of marked bradycardia or hypotension which may present as vertigo, syncope/presyncope, or orthostatic changes in blood pressure without compensatory tachycardia."><entity charOffset="22-32" id="DrugDDI.d546.s1.e0" origId="s1.p10" text="acebutolol" type="drug"/><negationtags>Patients treated with acebutolol plus catecholamine depletors should, therefore, be observed closely for evidence of marked bradycardia or hypotension which may present as vertigo, syncope/presyncope, or orthostatic changes in blood pressure &lt;xcope&gt;&lt;cue&gt;without&lt;/cue&gt; compensatory tachycardia&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d546.s2" origId="s2" text="Exaggerated hypertensive responses have been reported from the combined use of beta-adrenergic antagonists and alpha-adrenergic stimulants, including those contained in proprietary cold remedies and vasoconstrictive nasal drops."><entity charOffset="79-105" id="DrugDDI.d546.s2.e0" origId="s2.p38" text="beta-adrenergic antagonist" type="drug"/><entity charOffset="128-138" id="DrugDDI.d546.s2.e1" origId="s2.p40" text="stimulants" type="drug"/><pair e1="DrugDDI.d546.s2.e0" e2="DrugDDI.d546.s2.e1" id="DrugDDI.d546.s2.p0" interaction="true"/></sentence><sentence id="DrugDDI.d546.s3" origId="s3" text="Patients receiving beta-blockers should be warned of this potential hazard."><entity charOffset="19-33" id="DrugDDI.d546.s3.e0" origId="s3.p49" text="beta-blockers" type="drug"/></sentence><sentence id="DrugDDI.d546.s4" origId="s4" text="Blunting of the antihypertensive effect of beta-adrenoceptor blocking agents by nonsteroidal anti-inflammatory drugs has been reported."><entity charOffset="16-32" id="DrugDDI.d546.s4.e0" origId="s4.p55" text="antihypertensive" type="drug"/><entity charOffset="43-75" id="DrugDDI.d546.s4.e1" origId="s4.p56" text="beta-adrenoceptor blocking agent" type="drug"/><entity charOffset="80-116" id="DrugDDI.d546.s4.e2" origId="s4.p57" text="nonsteroidal anti-inflammatory drugs" type="drug"/><pair e1="DrugDDI.d546.s4.e0" e2="DrugDDI.d546.s4.e1" id="DrugDDI.d546.s4.p0" interaction="false"/><pair e1="DrugDDI.d546.s4.e0" e2="DrugDDI.d546.s4.e2" id="DrugDDI.d546.s4.p1" interaction="false"/><pair e1="DrugDDI.d546.s4.e1" e2="DrugDDI.d546.s4.e2" id="DrugDDI.d546.s4.p2" interaction="true"/></sentence><sentence id="DrugDDI.d546.s5" origId="s5" text="No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed."><entity charOffset="33-40" id="DrugDDI.d546.s5.e0" origId="s5.p62" text="digoxin" type="drug"/><entity charOffset="42-61" id="DrugDDI.d546.s5.e1" origId="s5.p63" text="hydrochlorothiazide" type="drug"/><entity charOffset="63-74" id="DrugDDI.d546.s5.e2" origId="s5.p64" text="hydralazine" type="drug"/><entity charOffset="76-90" id="DrugDDI.d546.s5.e3" origId="s5.p65" text="sulfinpyrazone" type="drug"/><entity charOffset="92-111" id="DrugDDI.d546.s5.e4" origId="s5.p66" text="oral contraceptives" type="drug"/><entity charOffset="113-124" id="DrugDDI.d546.s5.e5" origId="s5.p67" text="tolbutamide" type="drug"/><entity charOffset="129-137" id="DrugDDI.d546.s5.e6" origId="s5.p69" text="warfarin" type="drug"/><pair e1="DrugDDI.d546.s5.e0" e2="DrugDDI.d546.s5.e1" id="DrugDDI.d546.s5.p0" interaction="false"/><pair e1="DrugDDI.d546.s5.e0" e2="DrugDDI.d546.s5.e2" id="DrugDDI.d546.s5.p1" interaction="false"/><pair e1="DrugDDI.d546.s5.e0" e2="DrugDDI.d546.s5.e3" id="DrugDDI.d546.s5.p2" interaction="false"/><pair e1="DrugDDI.d546.s5.e0" e2="DrugDDI.d546.s5.e4" id="DrugDDI.d546.s5.p3" interaction="false"/><pair e1="DrugDDI.d546.s5.e0" e2="DrugDDI.d546.s5.e5" id="DrugDDI.d546.s5.p4" interaction="false"/><pair e1="DrugDDI.d546.s5.e0" e2="DrugDDI.d546.s5.e6" id="DrugDDI.d546.s5.p5" interaction="false"/><pair e1="DrugDDI.d546.s5.e1" e2="DrugDDI.d546.s5.e2" id="DrugDDI.d546.s5.p6" interaction="false"/><pair e1="DrugDDI.d546.s5.e1" e2="DrugDDI.d546.s5.e3" id="DrugDDI.d546.s5.p7" interaction="false"/><pair e1="DrugDDI.d546.s5.e1" e2="DrugDDI.d546.s5.e4" id="DrugDDI.d546.s5.p8" interaction="false"/><pair e1="DrugDDI.d546.s5.e1" e2="DrugDDI.d546.s5.e5" id="DrugDDI.d546.s5.p9" interaction="false"/><pair e1="DrugDDI.d546.s5.e1" e2="DrugDDI.d546.s5.e6" id="DrugDDI.d546.s5.p10" interaction="false"/><pair e1="DrugDDI.d546.s5.e2" e2="DrugDDI.d546.s5.e3" id="DrugDDI.d546.s5.p11" interaction="false"/><pair e1="DrugDDI.d546.s5.e2" e2="DrugDDI.d546.s5.e4" id="DrugDDI.d546.s5.p12" interaction="false"/><pair e1="DrugDDI.d546.s5.e2" e2="DrugDDI.d546.s5.e5" id="DrugDDI.d546.s5.p13" interaction="false"/><pair e1="DrugDDI.d546.s5.e2" e2="DrugDDI.d546.s5.e6" id="DrugDDI.d546.s5.p14" interaction="false"/><pair e1="DrugDDI.d546.s5.e3" e2="DrugDDI.d546.s5.e4" id="DrugDDI.d546.s5.p15" interaction="false"/><pair e1="DrugDDI.d546.s5.e3" e2="DrugDDI.d546.s5.e5" id="DrugDDI.d546.s5.p16" interaction="false"/><pair e1="DrugDDI.d546.s5.e3" e2="DrugDDI.d546.s5.e6" id="DrugDDI.d546.s5.p17" interaction="false"/><pair e1="DrugDDI.d546.s5.e4" e2="DrugDDI.d546.s5.e5" id="DrugDDI.d546.s5.p18" interaction="false"/><pair e1="DrugDDI.d546.s5.e4" e2="DrugDDI.d546.s5.e6" id="DrugDDI.d546.s5.p19" interaction="false"/><pair e1="DrugDDI.d546.s5.e5" e2="DrugDDI.d546.s5.e6" id="DrugDDI.d546.s5.p20" interaction="false"/><negationtags>&lt;xcope&gt;&lt;cue&gt;No&lt;/cue&gt; significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed&lt;/xcope&gt;.</negationtags></sentence></document>